Contract Services Contract Manufacturing
Thermo Fisher Enhances Cell Therapy Manufacturing with CTS Detachable Dynabeads™ for CD4+ and CD8+ T Cell Isolation
T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing Thermo Fishe...
December 05, 2024 | News
GBI Biomanufacturing Expands Services with Automated Sterile Fill-Finish Capabilities
GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expa...
November 21, 2024 | News
Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value
The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...
November 20, 2024 | News
SEKISUI Diagnostics Completes £15.7 Million cGMP Expansion for Enhanced Microbial Drug Substance Manufacturing in the UK
SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion&nbs...
November 15, 2024 | News
Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology
In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...
November 01, 2024 | Interview
Teijin and Hilleman Laboratories Forge Strategic CDMO Partnership to Advance Cell and Gene Therapy in Asia-Pacific
Teijin Limited and Hilleman Laboratories, a biotechnology company based in Singapore, announced the signing of a Memorandum of Understanding...
October 31, 2024 | News
Merck Invests €70 Million to Triple ADC Manufacturing Capacity at St. Louis Facility, Bolstering Bioconjugation Excellence
Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...
October 30, 2024 | News
WuXi Biologics Introduces High-Yield WuXia™ RidGS Platform, Setting New Standards in Non-Antibiotic Cell Line Development
WuXi Biologics , a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced the launch of WuXia™ RidGS, a hig...
October 29, 2024 | News
Asahi Kasei Medical Launches Planova™ FG1: A Next-Generation Virus Removal Filter for Enhanced Biopharmaceutical Manufacturing
Asahi Kasei Medical, a global leader in virus removal solutions, proudly announces the launch of the Planova™ FG1, a next-generation virus removal fi...
October 23, 2024 | News
Samsung Biologics Inks $1.24 Billion Manufacturing Agreement with Leading Asia Pharma
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contract manufacturing deal with an As...
October 23, 2024 | News
Samsung Biologics Introduces S-HiCon™ Platform to Optimize High-Concentration Drug Formulations
S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated...
October 15, 2024 | News
Centivax Partners with Australia’s BioCina for cGMP Manufacturing of Universal Influenza Vaccine
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax...
October 10, 2024 | News
SK bioscience Invests USD 3 Million in FinaBio to Enhance Next-Generation Conjugate Vaccine Development
SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bio...
October 08, 2024 | News
Thermo Fisher Scientific Launches Accelerator™ Drug Development: Transforming Drug Development with Comprehensive CDMO and CRO Services
Company Launches Accelerator™ Drug Development, 360° Contract Development and Manufacturing Organization (CDMO) and Contract Research Organizatio...
October 07, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
